CompletedPhase 2NCT00576407

Thymus Transplantation in DiGeorge Syndrome #668

Studying OBSOLETE: Anomaly of chromosome 22

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sumitomo Pharma Switzerland GmbH
Principal Investigator: M. Louise Markert, MD, PhD
Duke University Medical Center, Pediatrics, Allergy & Immunology
Intervention: Cultured Thymus Tissue for Implantation (CTTI)(biological)
Enrollment: 26 enrolled
Eligibility: All sexes
Timeline: 1991 – 2017

Study locations (1)

Duke University Medical Center, Durham, North Carolina, United States

Collaborators

National Institutes of Health (NIH) · National Institute of Allergy and Infectious Diseases (NIAID) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00576407 on ClinicalTrials.gov

← Back to all trials